Roughly, STS can divided into several
categories, namely those bearing reciprocal translocations
accounting for 15–20% of cases (e.g., synovial sarcoma,
Ewing sarcoma), those with specific mutations (e.g.,
gastrointestinal stromal tumor (GIST)) or deletions (e.g.,
rhabdoid tumor), those with amplifications (e.g., welldifferentiated
liposarcoma), and those with complex genomic
profiles (complex karyotypes).